Geographical variations of treatment disparities between Black and White patients with peripheral artery disease across the United States
Vogel Birgit, Erim Daniel, Pylypchuk Yuriy, Keever Rachel, Mehran Roxana, Dangas Katerina, Di Muro Francesca Maria, Sartori Samantha, Oliva Angelo, Dangas George, Krishnan Prakash, Yoon Harrison, Etter Katherine
Rivaroxaban for 18 Months versus 6 Months in Cancer Patients with Low-risk Pulmonary Embolism: ONCO PE Trial
Yamashita Yugo, Morimoto Takeshi, Muraoka Nao, Shioyama Wataru, Chatani Ryuki, Shibata Tatsuhiro, Nishimoto Yuji, Ono Koh, Kimura Takeshi
